Literature DB >> 22925410

Opioid substitution therapy clients' preferences for targeted versus general primary health-care outlets.

M Mofizul Islam1, Libby Topp, Katherine M Conigrave, Carolyn A Day.   

Abstract

INTRODUCTION AND AIMS: Opioid substitution therapy (OST) ideally constitutes a window of opportunity for the provision of essential primary health care (PHC) for OST clients. In the absence of such opportunities, however, OST clients access PHC from existing outlets, either general services or those targeted to specific groups. This study examined OST clients' current main source and preferred future outlets of PHC services and correlates of preferences. DESIGN AND METHODS: Anonymous interviews conducted with n = 257 clients of two public OST clinics in Sydney's inner-west.
RESULTS: Overall, 61% (n = 158) of participants reported currently accessing PHC primarily from general outlets (general practitioners or medical centres: 51%, hospital/emergence departments: 10%) and the remainder (39%, n = 99) from outlets that target specific groups (e.g. Aboriginal Medical Services, OST prescriber/clinics, drug user-targeted PHCs). Twenty-two percent reported discomfort disclosing drug use to their current PHC providers. However, the majority were satisfied with the care they received and reported a preference to remain with their current PHC providers for a range of reasons, most commonly familiarity with and trust in staff (56%) and not feeling judged about their drug use (49%). Nevertheless, 28% reported that they would access PHC through their OST clinic if it were available. DISCUSSION AND
CONCLUSIONS: PHC outlets that target specific groups appear to have an ongoing and important role in providing accessible health care to OST clients.
© 2012 Australasian Professional Society on Alcohol and other Drugs.

Entities:  

Mesh:

Year:  2012        PMID: 22925410     DOI: 10.1111/j.1465-3362.2012.00498.x

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  6 in total

1.  Ethical Issues in Providing and Promoting Contraception to Women with Opioid Use Disorder.

Authors:  Nadia Abbass; Tani Malhotra; Brooke Bullington
Journal:  J Clin Ethics       Date:  2022

2.  A prospective cohort study of hospital separations among people who inject drugs in Australia: 2008-2013.

Authors:  Dhanya Nambiar; Mark Stoové; Matthew Hickman; Paul Dietze
Journal:  BMJ Open       Date:  2017-08-18       Impact factor: 2.692

3.  Healthcare seeking among Swedish patients in opioid substitution treatment - a mixed methods study on barriers and facilitators.

Authors:  Katja Troberg; Karin Lundqvist; Helena Hansson; Anders Håkansson; Disa Dahlman
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-02-05

4.  Healthcare utilization for somatic conditions among Swedish patients in opioid substitution treatment, with and without on-site primary healthcare.

Authors:  Teodor Vikbladh; Katja Troberg; Anders Håkansson; Disa Dahlman
Journal:  BMC Health Serv Res       Date:  2022-07-29       Impact factor: 2.908

5.  A cross-sectional study describing factors associated with utilisation of GP services by a cohort of people who inject drugs.

Authors:  Dhanya Nambiar; Mark Stoové; Paul Dietze
Journal:  BMC Health Serv Res       Date:  2014-07-16       Impact factor: 2.655

Review 6.  Improving Access to Long-Acting Contraceptive Methods and Reducing Unplanned Pregnancy Among Women with Substance Use Disorders.

Authors:  Kirsten I Black; Carolyn A Day
Journal:  Subst Abuse       Date:  2016-05-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.